Key result
DCM-causing thin-filament mutations reduce cardiomyocyte contractility by ~20% to ~33% and suppress systolic calcium.
Why the study?
Dilated cardiomyopathy is a frequently occurring cardiac disorder with a degree of genetic inheritance, motivating investigation of initial disease triggers prior to remodeling.
DCM-causing mutations in thin-filament regulatory proteins directly induce hypocontractility, dysregulate calcium handling, and activate NFAT signaling prior to cellular remodeling.
Should not yet inform DCM management; hypothesis-generating in animal models, leaves open human translation.
Dilated cardiomyopathy (DCM) is a frequently occurring cardiac disorder with a degree of genetic inheritance. We have found that DCM mutations in proteins that regulate the contractile machinery cause alterations to contraction, calcium-handling, and some new signaling pathways that provide stimuli for disease development. We have used guinea pig cells that recapitulate human calcium-handling and introduced the mutations using adenovirus gene transduction to look at the initial triggers of disease before remodeling.
No takes yet. Share an insight, caveat, or question.
Robinson et al. (2020) studied Dilated cardiomyopathy (n=77). Adenoviral transduction of DCM mutations (TnT R131W, TnI K36Q, α-TM E40K) vs. Wild-type (WT) human recombinant TnI, TnT, and α-TM was evaluated on Cardiomyocyte contractility and calcium handling. Expression of DCM-causing mutations in thin-filament regulatory proteins uniformly reduced cardiomyocyte contractile magnitude by 19.8% to 32.6% and suppressed peak systolic calcium compared to wild-type controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: